---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-045210"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2024-04-09T23:59:59+00:00"
generated_at: "2026-06-04T00:59:06.344034+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Quoin shareholders approve issuance of shares to Alumni Capital LP

## Summary
- Special meeting on April 5, 2024 approved Alumni Issuance Proposal.
- Vote: 56,626 for, 23,469 against, 2,338 abstain; no broker non-votes.
- Approval allows issuance of up to maximum ordinary shares (ADSs) per Jan 25, 2024 purchase agreement.
- Alumni Capital LP is the counterparty; potential dilution from new share issuance.

## SEC filing metadata
- accession: 0001104659-24-045210
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2024-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465924045210/0001104659-24-045210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465924045210/tm2411437d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-045210
- JSON: https://secwatch.observer/filing/0001104659-24-045210.json
- Plain text: https://secwatch.observer/filing/0001104659-24-045210.txt

## Key facts
- Shareholder Votes
  Quoin Pharmaceuticals, Ltd. shareholders approved approve the issuance of the maximum number of the Company’s ordinary shares represented by ADSs issuable pursuant to the purchase agreement with Alumni Capital LP at the 2024-04-05 meeting.
  - Outcome: passed
  - Meeting: 2024-04-05
  source text: The shareholders approved the Alumni Issuance Proposal. The results of the voting for this proposal were as follows: For Against Abstain Broker Non-Votes 56,626 23,469 2,338 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671502/000110465924045210/0001104659-24-045210-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.